Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to analyze aquaporins expression of thymic epithelial tumors and to compare them with apparent diffusion coefficient(ADC) from ultra-high b-values, and to test a possibility of use of ADCuh to identify the pathological type of tumor.


Clinical Trial Description

Magnetic resonance (MR) diffusion-weighted imaging (DWI) measures water diffusion in biological tissue. The quantification of diffusion is described by the apparent diffusion coefficient (ADC),which largely depends on the number and separation of barriers.Thus, ADC can provide information regarding tissue microstructure.

According to the literature, ADC is also related to cell membrane permeability for water molecules.It is well known that cellular water transport depends on aquaporins (AQPs).In general,the expression of aquaporins might differ in several pathologic disorders. With reference to this fact,we hypothesize that AQPs expression may influence ADC in thymic epithelial tumors(TETs).Therefore,the aim of the present study is to analyze possible associations between ADC from ultra-high b-values and AQPs expression(ADCuh) in TETs and to use ADCuh to identify the pathological type of tumor. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03212027
Study type Observational
Source Tang-Du Hospital
Contact
Status Not yet recruiting
Phase N/A
Start date July 31, 2017
Completion date May 1, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05446935 - Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence N/A
Not yet recruiting NCT06200233 - Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor Phase 2
Recruiting NCT04667793 - Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor Phase 2
Recruiting NCT02724696 - French National Observatory of Patients With Thymic Epithelial Tumor
Recruiting NCT05667948 - Molecular Analysis and Treatment Options of Thymic Malignancies
Recruiting NCT04522687 - Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
Recruiting NCT06421805 - Establishing Prospective Mediastinal Tumor Database of PUMCH
Recruiting NCT04417660 - Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma Phase 2
Not yet recruiting NCT04517539 - Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors Phase 2
Recruiting NCT06301945 - Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors
Recruiting NCT05104736 - PT-112 in Subjects With Thymoma and Thymic Carcinoma Phase 2
Recruiting NCT03858582 - neoadjuvant_thymic Epithelial Tumor Phase 2
Recruiting NCT06311955 - Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor Phase 2